|
| ANTISAUVAGINE-30 Basic information |
Product Name: | ANTISAUVAGINE-30 | Synonyms: | D-PHE-HIS-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THR-ILE-NH2;(D-PHE11,HIS12)-SAUVAGINE (11-40);(D-PHE11,HIS12)-SAUVAGINE (11-40) TRIFLUOROACETATE SALT;H-D-PHE-HIS-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THE-ILE-OH;H-D-PHE-HIS-LEU-LEU-ARG-LYS-MET-ILE-GLU-ILE-GLU-LYS-GLN-GLU-LYS-GLU-LYS-GLN-GLN-ALA-ALA-ASN-ASN-ARG-LEU-LEU-LEU-ASP-THR-ILE-NH2;ANTISAUVAGINE-30;M.W. 3650.29 C161H274N48O46S;11-D-Phenylalanine-12-L-histidine-11-40-sauvagin | CAS: | 220673-95-0 | MF: | C161H273N47O47S | MW: | 3651.24 | EINECS: | | Product Categories: | CRF receptor and related | Mol File: | 220673-95-0.mol | |
| ANTISAUVAGINE-30 Chemical Properties |
RTECS | VQ6120000 | storage temp. | −20°C | form | Powder | Water Solubility | Soluble to 1 mg/ml in water |
| ANTISAUVAGINE-30 Usage And Synthesis |
Enzyme inhibitor | This highly selective CRF2 antagonist (MW = 3650.29 g/mol; CAS 220673-95-0; Sequence: D-Phe-His-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile- Glu-Lys-Gln-Glu-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2; Solubility: 5 mg/mL H2O; Alternate Name: [D-Phe 11 ,His 12 ]-Sauvagine (11- 40)) targets human Corticotropin-Releasing hormone (CRH) Receptor-2 subtypes CRF2β (Ki = 1.4 nM), with a much higher value of 154 nM for CRF1. (See also Astressin; K41448) Type-2 GPCRs reside in plasma membranes of hormone-sensitive cells and bind CRH, a peptide hormone and neurotransmitter involved in stress responses. Antisauvagine-30 blocks (pA2 = 8.49) sauvagine-stimulated accumulation of cAMP in HEK-mCRF2β cells. It also prevents stress-enhanced fear conditioning and MEK1/2- dependent activation of ERK1/2 in mice and suggesting a role for protein kinase signaling in the hippocampus and its modulation by CRF2 as a possible link between stress and fear memory. |
| ANTISAUVAGINE-30 Preparation Products And Raw materials |
|